Anika Therapeutics, Inc. (ANIK)
19.58
+0.35
(+1.82%)
USD |
NASDAQ |
Oct 09, 16:00
19.58
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Free Cash Flow (Quarterly) : -2.133M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.133M |
| March 31, 2026 | -6.277M |
| December 31, 2025 | 3.989M |
| September 30, 2025 | 4.983M |
| June 30, 2025 | -1.656M |
| March 31, 2025 | -2.954M |
| December 31, 2024 | 0.275M |
| September 30, 2024 | 3.20M |
| June 30, 2024 | -4.472M |
| March 31, 2024 | -1.934M |
| December 31, 2023 | 1.798M |
| September 30, 2023 | 5.744M |
| June 30, 2023 | -9.75M |
| March 31, 2023 | -5.007M |
| December 31, 2022 | -2.048M |
| September 30, 2022 | 1.018M |
| June 30, 2022 | 1.148M |
| March 31, 2022 | -3.195M |
| December 31, 2021 | 3.345M |
| September 30, 2021 | 0.778M |
| June 30, 2021 | 1.979M |
| March 31, 2021 | -2.848M |
| December 31, 2020 | 2.138M |
| September 30, 2020 | 5.594M |
| June 30, 2020 | 3.383M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.322M |
| December 31, 2019 | 12.75M |
| September 30, 2019 | 9.623M |
| June 30, 2019 | 4.369M |
| March 31, 2019 | 7.432M |
| December 31, 2018 | 9.85M |
| September 30, 2018 | 9.632M |
| June 30, 2018 | 3.731M |
| March 31, 2018 | 7.049M |
| December 31, 2017 | 4.505M |
| September 30, 2017 | 9.513M |
| June 30, 2017 | 4.029M |
| March 31, 2017 | 13.78M |
| December 31, 2016 | 4.438M |
| September 30, 2016 | 8.575M |
| June 30, 2016 | -4.488M |
| March 31, 2016 | 1.262M |
| December 31, 2015 | 8.077M |
| September 30, 2015 | 8.012M |
| June 30, 2015 | 10.02M |
| March 31, 2015 | 3.728M |
| December 31, 2014 | 14.12M |
| September 30, 2014 | 4.660M |
| June 30, 2014 | 6.322M |
| March 31, 2014 | 13.32M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -34.87M |
| MiMedx Group, Inc. | -10.67M |
| ABVC BioPharma, Inc. | -0.2444M |
| Intuitive Surgical, Inc. | 948.40M |
| Precigen, Inc. | -18.20M |